Skip to main content
OpenTrials

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

243 public trials 102 recruiting studies
Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

NCT06726161

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Research Facility Birmingham, Alabama, United States
  • Research Facility Phoenix, Arizona, United States
  • Research Facility Tucson, Arizona, United States
  • Research Facility Orange, California, United States
View all 13 locations
View Trial Details
Recruiting

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

NCT07331883

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Sanming First Hospital Sanming, Fujian, China
  • The Third Bethune Hospital of Jilin University Changchun, Jilin, China
  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

NCT07176650

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Oncology Physicians Network (OPN) - Los Alamitos /OPN Healthcare Glendale, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • D&H National Research Centers, LLC Margate, Florida, United States
View all 51 locations
View Trial Details
Recruiting

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

NCT07469319

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Aarhus University Hospital Aarhus, Central Jutland, Denmark
  • Regional Hospital Gødstrup Herning, Central Jutland, Denmark
  • Horsens Regional Hospital Horsens, Central Jutland, Denmark
  • Randers Regional Hospital Randers, Central Jutland, Denmark
View Trial Details

Related conditions